Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo antitumour activity in colorectal cancer

Beale, G, Haagensen, EJ, Thomas, HD et al. (8 more authors) (2016) Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo antitumour activity in colorectal cancer. British Journal of Cancer, 115 (6). pp. 682-690. ISSN 0007-0920

Abstract

Metadata

Authors/Creators:
  • Beale, G
  • Haagensen, EJ
  • Thomas, HD
  • Wang, L-Z
  • Revill, CH
  • Payne, SL
  • Golding, BT
  • Hardcastle, IR
  • Newell, DR
  • Griffin, RJ
  • Cano, C
Copyright, Publisher and Additional Information: (c) 2016 Cancer Research UK. All rights reserved. From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 4.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/
Keywords: Cancer therapy; Cell death; Colorectal cancer; Combination drug therapy
Dates:
  • Published: 6 September 2016
  • Accepted: 14 July 2016
  • Published (online): 16 August 2016
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Maths and Physical Sciences (Leeds) > School of Chemistry (Leeds) > Organic Chemistry (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 14 Nov 2018 13:12
Last Modified: 14 Nov 2018 13:12
Status: Published
Publisher: Springer Nature
Identification Number: https://doi.org/10.1038/bjc.2016.238
Related URLs:

Share / Export

Statistics